Rilutek (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Rilutek drug offered from sanofi-aventis U.S. LLC. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | riluzole |
SUBSTANCE NAME: | RILUZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1995-12-12 |
END MARKETING DATE: | 0000-00-00 |
Rilutek HUMAN PRESCRIPTION DRUG Details:
Item Description | Rilutek from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 1995-12-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0075-7700_3d0700b2-3cee-4276-8228-dbf608fb2612 |
PRODUCT NDC: | 0075-7700 |
APPLICATION NUMBER: | NDA020599 |
Other RILUZOLE Pharmaceutical Manufacturers / Labelers: